Health Canada has countered U.S. President Donald Trump’s assertion linking Tylenol use during pregnancy and childhood to autism. The department stated that acetaminophen, the active ingredient in Tylenol, is recommended for pain and fever during pregnancy, emphasizing its usage as prescribed by a healthcare provider at the lowest effective dose for the shortest duration. Health Canada emphasized the importance of treating fever and pain during pregnancy to prevent potential risks to the fetus.
Health Canada clarified that there is no definitive proof that following acetaminophen guidelines during pregnancy causes autism or other neurodevelopmental conditions. The department highlighted the long-standing safe use of acetaminophen by millions of Canadians over the years, including pregnant women and breastfeeding mothers.
The department explained that their advice on acetaminophen usage is based on thorough evaluations of scientific evidence. Health Canada continually monitors medication use in Canada and mentioned that Tylenol labels already contain clear instructions for safe use during pregnancy and breastfeeding. If new evidence indicates any risks, Health Canada assured that they would take necessary actions to update labels, inform healthcare providers, and offer guidance to Canadians.
In contrast, President Trump declared on Monday that the U.S. Food and Drug Administration (FDA) will advise physicians about a potential link between acetaminophen and autism, urging people not to use Tylenol. However, both experts and the manufacturer of Tylenol, Kenvue, stated that there is insufficient evidence to support this connection.
The Society of Obstetricians and Gynaecologists of Canada (SOGC) affirmed that Tylenol usage during pregnancy does not lead to neurodevelopmental disorders. Despite some claims suggesting a link between acetaminophen exposure during pregnancy and certain neurodevelopmental disorders, the SOGC emphasized that the evidence supporting these claims is weak and has been consistently disproved by scientific and regulatory bodies.
President Trump’s call for reconsidering the debunked connection between childhood vaccines and autism was also highlighted. He was supported by U.S. Health Secretary Robert F. Kennedy Jr., a vaccine critic who has expressed doubts about vaccine safety. Kennedy’s pledge to identify the cause of autism by September has raised concerns among experts who argue that autism has multifactorial origins involving genetic and environmental factors.
Overall, Health Canada and medical experts continue to emphasize the safe and appropriate use of acetaminophen during pregnancy, refuting any unfounded claims linking its use to autism.
